{
    "nctId": "NCT00768222",
    "briefTitle": "Coated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery",
    "officialTitle": "Pilot Evaluation of Cosmetic Outcome and Surgical Site Infection Rates of Coated VICRYL* Plus Antibacterial (Polyglactin 910) Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 101,
    "primaryOutcomeMeasure": "Mean Score on Cosmetic Outcome Visual Analog Scale (VAS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 18 years of age or older with written informed consent\n* Scheduled for a modified radical mastectomy\n* Surgical wound classified Class I/Clean using the CDC SSI Surgical Wound Classification\n\nExclusion Criteria:\n\n* Unable to give consent and unlikely to comply with study requirements and complete the 90-day follow up visit\n* Undergoing surgery for modified radical mastectomy with immediate breast reconstruction, cosmetic breast operations, reduction, expansion, insertion of prothesis, duct ectasia or infective breast disease or implant\n* Surgical wounds classified as Class II, III or IV using CDC SSI Surgical Wound Classification\n* Has inflammatory cancers or skin ulceration\n* Has known allergy or intolerance to triclosan\n* Has compromised wound healing or chronic immune deficiency, for example diabetes, prolonged steroid use, AIDS or substance abuse\n* Has serious heart and/or lung disease\n* Has skin scar history or family history\n* Has direct relationship to or involvement in this or other studies under the direction of the investigator or center\n* Received an experimental drug or device within 30 days prior to the planned start of treatment",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}